The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
AI in Healthcare spent 2019 tracking the steady evolution of AI and other advanced technologies, paying close attention to how they could change patient care forever. We’ve gathered 10 of the site’s most popular—and compelling—articles from the past 12 months.
President Trump signed the latest $1.4 trillion spending bills into law to fund the government and simultaneously gutted three taxes related to the Affordable Care Act: the health insurance tax, Cadillac tax and medical device tax.
Novartis may give away a new drug with a price tag above $2 million for free to some patients using a lottery-style program. The drug, Zolgensma, is a cure for a deadly inherited disease, spinal muscular atrophy, and the world’s most expensive drug.
